Dr. Rahimi serves as the Technical Board Member at Chemva, where he provides strategic guidance to the company in the consulting areas of biocompatibility, toxicology, chemistry (extractables & leachables), and materials/polymer science. Dr. Rahimi is a recognized expert in the MedTech industry specializes in biological evaluations across all development phases from a global perspective, covering Class I-III devices and combination products, with comprehensive experience working with various notified bodies and national regulatory authorities.‍Dr. Rahimi holds a B.Sc. in Chemistry, Ph.D. in coatings and polymeric materials, diplomat of the American board of toxicology accreditation (D.A.B.T.), and graduate certificate in statistics. He is a faculty of chemical characterization, materials science, and toxicology with AAMI (the Association for the Advancement of Medical Instrumentation) and co-chairs degradation-related medical device standards at the ISO/AAMI level and represent the US a biocompatibility, E&L, and materials expert.

‍

Mr. Taha serves as the Biocompatibility Specialist/Materials Engineer at Chemva, where he supports MedTech companies in the consulting areas of biocomptability, toxicology, chemistry (extractables & leachables), and materials/polymer science. Mr. Taha holds a B.Eng. in Polymer Engineering and has over five years of experience preparing toxicological risk assessments, biological evaluation plans and reports, and change control assessments.

‍

Kinza serves as a statistician at Chemva, where he supports MedTech companies in the consulting areas of designing studies and analyzing data to extract informative trends. Kinza holds a B.Sc. and M.Sc. in statistics and has over ten years of experience developing predicitve models for various industiries.

‍

Ashidah serves as a Toxicologist at Chemva, where he supports MedTech companies in the consulting areas of biocompatibility and toxicology. Ashidah holds a M.Sc. in toxicology and has over five years of experience preparing toxicological risk assessments, and biological evaluation plans and reports. She is also an expert locating analogues for toxicological risk assessments.